MD3773G2 - Agent for treating precancerous mucous membrane and tegument affections - Google Patents
Agent for treating precancerous mucous membrane and tegument affectionsInfo
- Publication number
- MD3773G2 MD3773G2 MDA20080148A MD20080148A MD3773G2 MD 3773 G2 MD3773 G2 MD 3773G2 MD A20080148 A MDA20080148 A MD A20080148A MD 20080148 A MD20080148 A MD 20080148A MD 3773 G2 MD3773 G2 MD 3773G2
- Authority
- MD
- Moldova
- Prior art keywords
- tegument
- affections
- agent
- mucous membrane
- oil
- Prior art date
Links
Abstract
The invention refers to medicine, particularly oncology and clinical pharmacology.The agent for treating precancerous mucous membrane and tegument affections includes ricinic oil, grapestone oil, patchouly oil and holy thistle oil in the following component ratio, mass %:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20080148A MD3773G2 (en) | 2008-05-30 | 2008-05-30 | Agent for treating precancerous mucous membrane and tegument affections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20080148A MD3773G2 (en) | 2008-05-30 | 2008-05-30 | Agent for treating precancerous mucous membrane and tegument affections |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3773F1 MD3773F1 (en) | 2008-12-31 |
MD3773G2 true MD3773G2 (en) | 2009-09-30 |
Family
ID=40255077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20080148A MD3773G2 (en) | 2008-05-30 | 2008-05-30 | Agent for treating precancerous mucous membrane and tegument affections |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3773G2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD493Z (en) * | 2011-06-29 | 2012-10-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for prophylaxis of postradiation complications in oncological diseases |
MD783Z (en) * | 2013-10-08 | 2015-01-31 | Адриан КИШКА | Method for treating chronic atrophic gastritis |
-
2008
- 2008-05-30 MD MDA20080148A patent/MD3773G2/en not_active IP Right Cessation
Non-Patent Citations (2)
Title |
---|
Matcovschi C, Procopişin V, Parii B., Ghid farmacoterapeutic, Chişinău, 2006, p. 1287. * |
Matcovschi C., Procopişin V., Parii B. Ghid farmacoterapeutic, Chişinău, 2006, p. 1287 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD493Z (en) * | 2011-06-29 | 2012-10-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for prophylaxis of postradiation complications in oncological diseases |
MD783Z (en) * | 2013-10-08 | 2015-01-31 | Адриан КИШКА | Method for treating chronic atrophic gastritis |
Also Published As
Publication number | Publication date |
---|---|
MD3773F1 (en) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
EP2493464A4 (en) | Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms | |
IN2012DN02805A (en) | ||
BRPI0908503A2 (en) | particle less than 2mm in diameter, and composition for tissue treatment | |
UA104005C2 (en) | 2-oxo-1,2-dihydro-quinoline modulators of immune function | |
IN2012DN02735A (en) | ||
IN2012DN02730A (en) | ||
IN2012DN00754A (en) | ||
EA201170227A1 (en) | ИМИДАЗОЛКАРБОКСАМИДЫ | |
TN2011000414A1 (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof | |
MX2013002975A (en) | Estrogen receptor modulators and uses thereof. | |
MY162146A (en) | Pharmaceutical composition | |
IN2012DN00971A (en) | ||
IN2012DN00624A (en) | ||
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
MX2011000255A (en) | Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer. | |
MX2012000396A (en) | Methods and compositions for use in cellular therapies. | |
WO2010083385A3 (en) | Compounds for reducing drug resistance and uses thereof | |
MX2010006206A (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases. | |
IN2012DN02471A (en) | ||
NZ589517A (en) | A pharmaceutical composition comprising rebamipide | |
MX2011006725A (en) | Combination of aurora kinase inhibitors and anti-cd20 antibodies. | |
WO2009114461A3 (en) | Angiotensin (1-7) dosage forms and uses thereof | |
MX2013013649A (en) | Quinone compounds for treating ape1 mediated diseases. | |
WO2010033167A3 (en) | Anti-thrombin aptamer formulations and methods for use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |